Literature DB >> 11108744

In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity.

A Zambon1, S S Deeb, A Bensadoun, K E Foster, J D Brunzell.   

Abstract

Hepatic lipase (HL) is a key player in lipoprotein metabolism by modulating, through its lipolytic activity, the triglyceride (TG) and phospholipid content of apolipoprotein B (apoB)-containing lipoproteins and of high density lipoproteins (HDL), thereby affecting their size and density. A new and separate role has been suggested for HL in cellular lipoprotein metabolism, in which it serves as a ligand promoting cellular uptake of apoB-containing remnant lipoproteins and HDL. We tested the hypothesis that HL has both a lipolytic and a nonlipolytic role in human lipoprotein metabolism, by measuring lipid plasma concentrations, lipoprotein density distribution by density gradient ultracentrifugation, and lipoprotein composition, in three subjects with HL deficiency: two of the patients (S-1 and S-3) were characterized as having neither plasma HL activity nor detectable HL protein; the third subject (S-2) had no plasma HL activity but a detectable amount (35.5 ng/ml) of HL protein. All HL-deficient subjects showed a severalfold increase in lipoprotein TG content across the lipoprotein density spectrum [very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL), and HDL] as compared with control subjects. They also had remarkably more buoyant LDL particles (LDL-R(f) = 0.342;-0.394) as compared with the control subjects (LDL-R(f) = 0.303). Subjects S-1 and S-3 (no HL activity or protein) presented with a distinct increase in cholesterol and apoB levels in the IDL and VLDL density range as compared with patient S-2, with detectable HL protein, and the control subjects. This study provides evidence in humans that HL indeed plays an important role in lipoprotein metabolism independent of its enzymatic activity: in particular, inactive HL protein appears to affect VLDL and IDL particle concentration, whereas HL enzymatic activity seems to influence VLDL-, IDL-, LDL-, and HDL-TG content and their physical properties.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108744

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity.

Authors:  Verónica Miksztowicz; Laura Schreier; Mary McCoy; Diego Lucero; Eduardo Fassio; Jeffrey Billheimer; Daniel J Rader; Gabriela Berg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

Review 2.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

3.  Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase.

Authors:  Sung-Joon Lee; Sujata Kadambi; Kenneth C-W Yu; Christopher David; Salman Azhar; Allen D Cooper; Sungshin Y Choi
Journal:  J Lipid Res       Date:  2004-11-01       Impact factor: 5.922

4.  High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

Authors:  Mariko Tani; Katalin V Horvath; Benoit Lamarche; Patrick Couture; John R Burnett; Ernst J Schaefer; Bela F Asztalos
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

5.  Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species.

Authors:  Yanbo Yang; Takashi Kuwano; William R Lagor; Carolyn J Albert; Siobhan Brenton; Daniel J Rader; David A Ford; Robert J Brown
Journal:  Lipids       Date:  2014-04-29       Impact factor: 1.880

6.  A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.

Authors:  S Imamura; J Kobayashi; K Nakajima; S Sakasegawa; A Nohara; T Noguchi; M A Kawashiri; A Inazu; S S Deeb; H Mabuchi; J D Brunzell
Journal:  J Lipid Res       Date:  2008-03-14       Impact factor: 5.922

7.  Association of LIPC -250G>A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.

Authors:  Li Meng; Yin Ruixing; Li Yiyang; Long Xingjiang; Li Kela; Liu Wanying; Zhang Lin; Lin Weixiong; Yang Dezhai; Pan Shangling
Journal:  Lipids Health Dis       Date:  2010-03-11       Impact factor: 3.876

8.  Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations.

Authors:  Hiroshi Iijima; Mitsuru Emi; Manabu Wada; Makoto Daimon; Sayumi Toriyama; Satoru Koyano; Hidenori Sato; Paul N Hopkins; Steven C Hunt; Isao Kubota; Sumio Kawata; Takeo Kato
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

9.  Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.

Authors:  Zengxuan Nong; Herminia Gonzalez-Navarro; Marcelo Amar; Lita Freeman; Catherine Knapper; Edward B Neufeld; Beverly J Paigen; Robert F Hoyt; Jamila Fruchart-Najib; Silvia Santamarina-Fojo
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 10.  Molecular processes that handle -- and mishandle -- dietary lipids.

Authors:  Kevin Jon Williams
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.